You searched for "prostate"
25 Years of Prostate Cancer UK
8 February 2022
| Matthew Hobbs, Caroline Moore (Prof), Ananya Choudhury (Prof), Johann De Bono (Prof)
|
URO - Urologic Oncology
As leading men’s health charity, Prostate Cancer UK, celebrates its 25th anniversary, top researchers reflect on the huge progress in testing, treatment and support for men over the past 25 years. 25 years of beating prostate cancer together Matthew Hobbs,...
Can dogs smell prostate cancer?
4 March 2025
| Stephanie Smith, Rob Mills, Colin Cooper, Daniel Brewer
|
URO - Urologic Oncology
For centuries we have known that man’s best friend has an exceptional sense of smell. ‘Sniffer’ dogs are found in a wide range of roles, including drug and explosive detection as part of airport security, helping emergency services locate survivors...
Prostate cancer series: diagnostics 1
8 January 2025
| Abida Sultana, Henry Tam, Hashim U Ahmed (Prof), Lap Yan Leung
|
URO - Urologic Oncology
- Click here for Part 2 - A 58-year-old male is referred to your rapid access prostate clinic with a prostate specific antigen (PSA) of 6.0ng/ml. He has no lower urinary tract symptoms (LUTS), past medical history (PMH), or family...
Impact of MetS on prostate cancer (PCa)
1 November 2016
| Gokul Vignesh Kanda Swamy
|
URO - Urologic Oncology
Metabolic syndrome is associated with an increased risk of finding prostate cancer (PCa) overall and high-grade disease on biopsy. The first objective was to determine if MetS is associated with higher final PCa stage and grade on radical prostatectomy (RP)...
Prostate Cancer – Diagnosis and Clinical Management
1 January 2016
| Tim Lane
|
URO - Urologic Oncology
This rather modest looking paperback actually punches well beyond its humble appearance. There are of course the predictable sub-sections appropriate to any prostate cancer text – but that said this relatively small-volume affair (compared to some of the Goliaths out...
Management of Prostate Cancer: A Multidisciplinary Approach
4 September 2020
| Jay Khastgir
|
URO - Urologic Oncology
This is an excellent textbook which comprehensively covers the vast field of prostate cancer. The editors, who have co-ordinated phase III European Organisation for Research and Treatment of Cancer (EORTC) trials, have brought together a large array of well-known international...
Abiraterone acetate in men with castration-resistant prostate cancer
1 November 2017
| Pravisha Ravindra
|
URO - Urologic Oncology
With emerging results from the Stampede and Latitude studies, abiraterone has taken the forefront in the management of metastatic prostate cancer while researchers try to identify the ideal timing for administration. It is a potent inhibitor of CYP17 which results...
Results of HoLEP in patients with prostate cancer and LUTS
Holmium laser enucleation of the prostate (HoLEP) is recommended for the management of benign prostatic obstruction. With similar functional outcomes and less morbidity compared to transurethral resection of the prostate (TURP), it has become a useful tool in the armament...
Metabolic syndrome and prostate cancer recurrence in a veterans’ cohort
1 November 2015
| Pravisha Ravindra
|
URO - Urologic Oncology
This study explored the relationship between metabolic syndrome and localised prostate cancer recurrence in patients who had received active treatment (external beam radiation therapy – EBRT, radical retropubic prostatectomy – RRP, or brachytherapy). The definition of metabolic syndrome adopted was...
The EP2 receptor – a novel target for prostate cancer?
This basic science paper sets out to evaluate the effects that celecoxib, a selective cyclo-oxygenase-2 (COX-2) inhibitor, have on prostate cancer cell lines and evaluated the mechanisms behind these effects. COX-2 induces the production of prostaglandins, which promote cell proliferation...The role of transperineal template biopsies in the diagnosis of prostate cancer
1 March 2014
| Andrew Chetwood, Archana Fernando, Stephen Langley (Prof), Bruce Montgomery, Simon Bott
|
URO - Urologic Oncology
The case In 2002, Mr A, a 64-year-old software engineer, was referred by his GP for further investigation of a raised prostate specific antigen (PSA) of 6.2. His prostate felt benign. He underwent transrectal ultrasound guided (TRUS) prostate biopsies. This...
A guide to local anaesthetic transperineal prostate biopsy
2 November 2023
| Petre Cristian Ilie, Utsav Reddy, Lee Smith
|
URO - Urologic Oncology
In the UK, nearly 100,000 men undergo a prostate biopsy annually, a figure projected to double in the next decade [1]. In recent years, we have observed a paradigm shift in urological practice in numerous UK hospitals. The conventional transrectal,...
